Efficacy of team-based care for distressed patients in secondary prevention of chronic coronary heart disease: a randomized controlled trial

Efficacy of team-based care for distressed patients in secondary prevention of chronic coronary heart disease: a randomized controlled trial - TEACH

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

DRKS

Registry ID

DRKS00020824

Enrollment

440

Registered

2020-06-04

Start date

2020-11-17

Completion date

Unknown

Last updated

2025-10-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

I20-I25 F32 F41 F43 F54

Interventions

Group 1: 12 months of usual care+ care manager support & feedback adressing psychosocial distress and CHD risk factors + educational patient website / online chat (team care) Group 2: 12 months of tre

Eligibility

Sex/Gender

All

Age

18 Years to 85 Years

Inclusion criteria

Inclusion criteria: 1. Currently or recently (12 or score on Perceived Stress Scale [PSS-4] >5) at =2.5 months after iinitial prescreening 3. Insufficient cardiac risk factor control (based on ESC guideline criteria) at =2.5 months after initial prescreening

Exclusion criteria

Exclusion criteria: 1. Acute coronary syndrome or cardiac surgery between prescreening and enrolment 2. Comorbidities with estimated survival <1 year 3. severe mental illness (e.g., acute psychoses, addiction other than tobacco) 4. severe cognitive impairment like dementia or impaired ability to communicate 5. participation in another treatment trial likely to affect the relevant endpoints or interfering with the trial procedures

Design outcomes

Primary

Measure	Time frame
Response to treatment defined as =50% increase in HRQoL (HeartQoL score) from baseline to month 12 (i.e. (score12 months-score baseline)/(42-score baseline)=50%, where 42 is the maximum score).	—

Secondary

Measure	Time frame
Change from baseline to month 12 in: (1) continuous HeartQoL score (2) Composite medical risk factor score (systolic blood pressure + LDL cholesterol + HbA1c + smoking status + physical activity); (3) psychosocial status (distress etc.); (4) single elements of composite endpoint; medication adherence, physical exercise, dietary pattern, smoking status, angina symptoms; (5) treatment satisfaction; (6) number of adverse cardiovascular events; (7) HRQoL and variables listed under (1)-(5) until end of follow-up	—

Measure

Time frame

Change from baseline to month 12 in: (1) continuous HeartQoL score (2) Composite medical risk factor score (systolic blood pressure + LDL cholesterol + HbA1c + smoking status + physical activity); (3) psychosocial status (distress etc.); (4) single elements of composite endpoint; medication adherence, physical exercise, dietary pattern, smoking status, angina symptoms; (5) treatment satisfaction; (6) number of adverse cardiovascular events; (7) HRQoL and variables listed under (1)-(5) until end of follow-up

—

Countries

Germany

Contacts

Public ContactMonika Sadlonova

Universitätsmedizin Göttingen, Klinik für Psychosomatische Medizin und Psychotherapie

Monika.Sadlonova@med.uni-goettingen.de+49-551-39-68296

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 17, 2026